Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer

por Towns, K., Bedard, P.L., Verma, S.
Publicado 2008

A242 DELAYED STEROID TAPER MAY REDUCE RISK OF RELAPSE IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED HEPATOTOXICIT

por Almousawi, F, Butler, M, Bedard, P, Spreafico, A, Siu, L, Cunningham, M
Publicado 2023

Quality of life and understanding of disease status among cancer patients of different ethnic origin

por Tchen, N, Bedard, P, Yi, Q-L, Klein, M, Cella, D, Eremenco, S, Tannock, I F
Publicado 2003

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

por Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J
Publicado 2010

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

por Spreafico, A, Delord, J-P, De Mattos-Arruda, L, Berge, Y, Rodon, J, Cottura, E, Bedard, P L, Akimov, M, Lu, H, Pain, S, Kaag, A, Siu, L L, Cortes, J
Publicado 2015

Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells

por Bassey-Archibong, B I, Kwiecien, J M, Milosavljevic, S B, Hallett, R M, Rayner, L G A, Erb, M J, Crawford-Brown, C J, Stephenson, K B, Bédard, P-A, Hassell, J A, Daniel, J M
Publicado 2016

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

por Sahebjam, S, Bedard, P L, Castonguay, V, Chen, Z, Reedijk, M, Liu, G, Cohen, B, Zhang, W-J, Clarke, B, Zhang, T, Kamel-Reid, S, Chen, H, Ivy, S P, Razak, A R A, Oza, A M, Chen, E X, Hirte, H W, McGarrity, A, Wang, L, Siu, L L, Hotte, S J
Publicado 2013